Contact us!     1-877-355-8012  /  [email protected]

Vielight Logo
0

Your cart is currently empty.

Vielight Shop
0

Your cart is currently empty.

Vielight Logo
0

Your cart is currently empty.

Shop now

Vielight for US Veterans

For Veterans

At Vielight, we are honored to have partnered with the US Department of Veterans Affairs for over a decade.

VA providers may prescribe Vielight devices to Veterans at full cost coverage, at their discretion.

We are incorporated in the USA and fully compliant with federal procurement regulations, ensuring a seamless purchasing process.

Interested in a Vielight device?

Ask your VHA provider if Vielight is right for you.

Join thousands of Veterans using Vielight’s non-invasive technology to support cognitive wellness and performance.

Our devices are listed on the GSA Advantage website.

Vielight x US VA Brochure GSA Advantage Link

The Vielight Neuro: selected by the VA for traumatic brain injury care

In 2018, the VA’s Center for Compassionate Care Innovation (CCI) partnered with traumatic brain injury clinics in Boston to explore a home-based LED therapy program utilizing Vielight technology.

This innovative approach has successfully treated over 100 Veterans, leading to the CCI’s approval of the Vielight Neuro for continued use in supporting Veterans with traumatic brain injury.

See article

Meet the Neuro Duo 4

The Vielight Neuro Duo 4 is a next-generation brain stimulation device that supports cognitive function, memory, and brain connectivity. It uses specialized high-powered LEDs to target key areas of the brain, including the Default Mode Network.

 

The device offers two settings designed to support mental wellness: Alpha mode promotes relaxation and improves sleep quality, while Gamma mode enhances focus and mental clarity.

 

  1. 20 minutes per session
  2. Results in 4 to 8 weeks
  3. Easy to use, safe, and painless
See devices See research

What is the Vielight Neuro?

Video Placeholder

Advancing veteran wellness through research

Vielight devices have been the focus of multiple studies addressing service-related conditions.

Traumatic Brain Injury Published in 2024
Completed Clinical trial (n=43) Conducted with the

Neuro Gamma

The Effect of Intranasal Plus Transcranial Photobiomodulation on Neuromuscular Control in Individuals with Repetitive Head Acceleration Events

A University of Utah study explored the effects of the Vielight Neuro Gamma device on brain injuries. The study involved 43 participants with mild traumatic brain injury or related symptoms. Results showed significant improvements in reaction time, grip strength, and balance after 8-10 weeks of at-home photobiomodulation treatment.

In collaboration with the University of Utah,

and Mount Sinai Hospital

See summary See published study
×
PTSD Published in 2019
Completed Clinical study Conducted with the

Neuro Alpha

Improvements in Gulf War Illness Symptoms After Near-Infrared Transcranial and Intranasal Photobiomodulation: Two Case Reports

This study examines the effects of photobiomodulation therapy on two Gulf War veterans suffering from Gulf War illness, a condition marked by symptoms like fatigue, pain, cognitive dysfunction, and more. The veterans used the Neuro Alpha every other day for 12 weeks, with results showing symptom improvements. One veteran no longer met the criteria for Gulf War illness, and the other saw significant reductions in fatigue, pain, and cognitive symptoms.

In collaboration with the University of California,
and the Veterans Affairs USA

See published study
PTSD Published in 2019
Completed Clinical study (n=47) Conducted with the

MIP 810 and MIP 633

Scalp Application of LED Therapy to Improve Thinking and Memory in Veterans With Gulf War Illness

In 2014, the VA Boston Healthcare System conducted a study involving 47 veterans with Gulf War illness. The study tested Vielight’s intranasal red and near-infrared light therapy to support cognitive function and improve blood flow. The painless, non-invasive transcranial LED treatment generated no heat. All devices used were approved by the VABHS safety committee. The treatment was classified by the FDA as low-risk.

In collaboration with the Veterans Affairs USA

See summary See published study

Thank you

Your message has been sent.

Are you a VA researcher?

We would love to collaborate!






    0